Centerpoint Advisors, LLC Ocular Therapeutix, Inc Transaction History

Centerpoint Advisors, LLC

  • $288 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 14, 2022
BUY
$6.16 - $12.07 $6,160 - $12,070
1,000 Added 41.84%
3,390 $24,000
Q2 2021

Jul 26, 2021
BUY
$13.43 - $19.16 $15,310 - $21,842
1,140 Added 91.2%
2,390 $34,000
Q1 2020

Apr 23, 2020
SELL
$3.95 - $7.4 $5,008 - $9,383
-1,268 Reduced 50.36%
1,250 $6,000
Q2 2019

Jul 17, 2019
BUY
$2.46 - $4.52 $6,194 - $11,381
2,518 New
2,518 $11,000

Others Institutions Holding OCUL

# of Institutions
172
Shares Held
138M
Call Options Held
150K
Put Options Held
225K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $764M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Centerpoint Advisors, LLC Portfolio

Follow Centerpoint Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centerpoint Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Centerpoint Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email